Back to Market Feed

IMATINIB MESYLATE 400 MG TAB

Imatinib
$2.7670per EA

Strength

400 mg/1

NDC

43598034530

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/23/2025

Active Ingredients

IMATINIB MESYLATE

Approval Type

Generic (ANDA)

FDA Application

ANDA206547

On Market Since

8/13/2018

Pharmacological Classes

Bcr-Abl Tyrosine Kinase Inhibitors
Cytochrome P450 2D6 Inhibitors
Cytochrome P450 3A4 Inhibitors
Kinase Inhibitor

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

+18.9%

5Y

-34.2%

All

-84.3%

Generic Alternatives

1 alternative • Same active ingredient

IMATINIB MESYLATE 400 MG TAB
Generic
43598034531•Dr. Reddy's Laboratories Inc.
$3.0339
+10% more

Related Drugs

Same classification

SERTRALINE HCL 25 MG TABLET
Generic
00904692461•Major Pharmaceuticals
$0.0300
per EA
SERTRALINE HCL 25 MG TABLET
Generic
16714061101•NorthStar Rx LLC
$0.0300
per EA
SERTRALINE HCL 25 MG TABLET
Generic
16714061104•NorthStar Rx LLC
$0.0300
per EA
SERTRALINE HCL 25 MG TABLET
Generic
16714061105•NorthStar Rx LLC
$0.0300
per EA
SERTRALINE HCL 25 MG TABLET
Generic
16714061106•NorthStar Rx LLC
$0.0300
per EA
SERTRALINE HCL 25 MG TABLET
Generic
16729021515•Accord Healthcare Inc.
$0.0300
per EA
SERTRALINE HCL 25 MG TABLET
Generic
16729021516•Accord Healthcare Inc.
$0.0300
per EA
SERTRALINE HCL 25 MG TABLET
Generic
23155075705•Heritage Pharmaceuticals Inc.
$0.0300
per EA
SERTRALINE HCL 25 MG TABLET
Generic
23155075709•Heritage Pharmaceuticals Inc.
$0.0300
per EA
SERTRALINE HCL 25 MG TABLET
Generic
31722014505•Camber Pharmaceuticals Inc.
$0.0300
per EA